PRECIPIO, INC. Sales-type Lease, Revenue
PRECIPIO, INC. (PRPO) reported Sales-type Lease, Revenue of $0 for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesTypeLeaseRevenue · last filed 2023-08-11
- PRECIPIO, INC. sales-type lease, revenue for the quarter ending 2023-06-30 was $0.00.
- PRECIPIO, INC. sales-type lease, revenue for the quarter ending 2023-03-31 was $0.00.
- PRECIPIO, INC. sales-type lease, revenue for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. sales-type lease, revenue for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIPIO, INC. sales-type lease, revenue for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- PRECIPIO, INC. sales-type lease, revenue for fiscal 2021 was $200.00K, a 100.00% increase from fiscal 2020.
- PRECIPIO, INC. sales-type lease, revenue for fiscal 2020 was $100.00K.
| Period end | Sales-type Lease, Revenue 3 month | Sales-type Lease, Revenue 6 month | Sales-type Lease, Revenue 9 month | Sales-type Lease, Revenue 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $0.00 derived: sum of 3 quarters · filed 2023-08-11 | $0.00 derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-05-12 | $0.00 derived: sum of 3 quarters · filed 2023-05-12 | $0.00 derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-08-11 | $0.00 10-K · filed 2023-03-30 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2023-08-11 | $0.00 10-Q · filed 2022-11-10 | $100.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 | $100.00K derived: sum of 3 quarters · filed 2023-08-11 | $200.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-12 | $100.00K derived: sum of 2 quarters · filed 2023-05-12 | $200.00K derived: sum of 3 quarters · filed 2023-05-12 | $200.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $200.00K derived: sum of 2 quarters · filed 2023-03-30 | $200.00K derived: sum of 3 quarters · filed 2023-03-30 | $200.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-10 | $100.00K derived: sum of 2 quarters · filed 2022-11-10 | $100.00K 10-Q · filed 2022-11-10 | $300.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | $100.00K 10-Q · filed 2022-08-11 | $200.00K derived: sum of 3 quarters · filed 2022-08-11 | $200.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $100.00K 10-Q · filed 2021-05-14 | $200.00K derived: sum of 2 quarters · filed 2022-03-30 | $200.00K derived: sum of 3 quarters · filed 2022-03-30 | $200.00K derived: sum of 4 quarters · filed 2022-03-30 |
| 2020-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $100.00K derived: sum of 2 quarters · filed 2022-03-30 | $100.00K derived: sum of 3 quarters · filed 2022-03-30 | $100.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | $0.00 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |